E2F Transcription Factor 8 (E2F8) (Middle Region) Peptide
Quick Overview for E2F Transcription Factor 8 (E2F8) (Middle Region) Peptide (ABIN976087)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-E2F8 antibody (Catalog #: ARP47684_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- E2F8 (E2F Transcription Factor 8 (E2F8))
-
Background
-
E2F transcription factors, such as E2F8, are essential for orchestrating expression of genes required for cell cycle progression and proliferation (Christensen et al., 2005 [PubMed 16179649]).
Alias Symbols: FLJ23311, E2F-8
Protein Interaction Partner: E2A
Protein Size: 867 -
Molecular Weight
- 94 kDa
-
Gene ID
- 79733
-
NCBI Accession
- NM_024680, NP_078956
-
UniProt
- A0AVK6
Target
-